Enthera Pharmaceuticals

First-in-class biologics for underserved autoimmune conditions

Milan, Italy · Founded 2016 · $73.7M raised

Headquarters
Milan
Employees
1–10
Founded
2016
Business Model
B2B
Total Funding
$73.7M
Last Round
$38.5M Series AJan 2021
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Enthera Pharmaceuticals is a Milan-based biotech company developing first-in-class biologics for underserved autoimmune conditions, with a focus on Type 1 Diabetes and Inflammatory Bowel Disease. Their pioneering therapeutic approach targets the IGFBP3/TMEM219 stem cell apoptosis pathway to preserve and restore endogenous organ function. Their lead program, Ent001, is the only drug in development aimed at restoring pancreatic beta cells in T1D and original intestine structure in IBD. Founded in 2016, the company is backed by BiovelocITA, Sofinnova Partners, and JDRF.

Summary

Enthera Pharmaceuticals is a Biotech company based in Milan, Italy, founded in 2016. It has raised $73.7M in total across 3 rounds, most recently a $38.5M Series A round in Jan 2021. Investors include Sofinnova Partners, AbbVie Ventures and BiovelocITA.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries A ExtensionJan 2021
$38.5M

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Enthera Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/enthera-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/enthera-pharmaceuticals" alt="Enthera Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>